Confirming you are not from the U.S. or the Philippines

By giving this statement, I explicitly declare and confirm that:
  • I am not a U.S. citizen or resident
  • I am not a resident of the Philippines
  • I do not directly or indirectly own more than 10% of shares/voting rights/interest of the U.S. residents and/or do not control U.S. citizens or residents by other means
  • I am not under the direct or indirect ownership of more than 10% of shares/voting rights/interest and/or under the control of U.S. citizen or resident exercised by other means
  • I am not affiliated with U.S. citizens or residents in terms of Section 1504(a) of FATCA
  • I am aware of my liability for making a false declaration.
For the purposes of this statement, all U.S. dependent countries and territories are equalled to the main territory of the USA. I accept full responsibility for the accuracy of this declaration and commit to personally address and resolve any claims or issues that may arise from a breach of this statement.
We are dedicated to your privacy and the security of your personal information. We only collect emails to provide special offers and important information about our products and services. By submitting your email address, you agree to receive such letters from us. If you want to unsubscribe or have any questions or concerns, write to our Customer Support.
Octa trading broker
Open trading account
Back

Moderna Akan Ajukan Izin Penggunaan Darurat AS Untuk Vaksin COVID-19-nya Pada Hari Senin

Moderna Inc mengumumkan akan mengajukan izin penggunaan darurat vaksin COVID-19-nya di AS pada hari Senin, seperti dilansir Reuters.

Poin-poin tambahan

"Akan mengajukan pada hari Senin untuk persetujuan bersyarat vaksinnya di UE."

"Vaksin COVID-19 94,1% efektif dalam analisis studi fase 3 setelah 196 kasus COVID-19."

"Vaksin COVID-19 100% efektif melawan COVID-19 parah dalam uji coba fase 3."

"Uji coba vaksin COVID-19 fase 3 memiliki 30 kasus parah, semua di sisi plasebo, termasuk 1 kematian."

"Pertemuan Komite Penasihat FDA AS dijadwalkan pada 17 Desember."

"Peluncuran uji coba vaksin COVID-19 pada remaja diharapkan bisa dilakukan sebelum akhir tahun."

"Tidak ada masalah keamanan serius baru yang teridentifikasi sejak 16 November dalam uji coba fase 3."

"Memperkirakan memiliki 20 juta dosis vaksin yang tersedia di AS tahun ini, dapat mulai dikirim segera setelah izin."

"Kemanjuran vaksin COVID-19 konsisten di seluruh usia, ras dan etnis, dan demografi jenis kelamin."

Reaksi pasar

Berita ini sepertinya tidak berdampak signifikan terhadap sentimen pasar. Saat penulisan, S&P 500 Futures turun 0,24% hari ini di 3.627.

Analisis Harga Indeks Dolar AS: Penurunan Ekstra Dalam Proses

Momentum sisi bawah DXY telah dipercepat akhir-akhir ini setelah menembus level Fibo di wilayah 91,90 dan garis support 8-bulan di dekat 91,80. Oleh
Read more Previous

Analisis EUR/USD: Ada Ruang Untuk Uji 1,20 (Dan Di Atasnya)

EUR/USD memperpanjang kenaikan untuk sesi lainnya dan secara bertahap bergerak mendekati rintangan psikologis di 1,20. Kelanjutan kenaikan awalnya me
Read more Next